Background: Repair of tetralogy of Fallot (TOF) and transposition of the great arteries (TGA), the most common conotruncal congenital heart defects, often results in right ventricular (RV) volume and/or pressure overload. RV failure often ensues over time. Myocardial fibrosis may be an important correlate of RV dysfunction and adverse RV remodeling. Delayed contrast enhancement cardiac MRI (DEMRI) is known to be a sensitive technique for determining the presence, location and extent of myocardial fibrosis in vivo. The purpose of this study was to correlate the presence, location and extent of myocardial fibrosis on DEMRI with RV volumes and function, as well as QRS duration in patients with repaired TOF or TGA. Methods: Twenty seven patients with TOF or TGA were prospectively identified and underwent cine and DEMRI. Measurements of RV morphology and function were assessed on the cine images, and the extent of hyperenhancement (HE) was assessed on delayed enhancement images. QRS duration was measured from the standard electrocardiogram. Results: All patients, regardless of RV size and function, had evidence of some myocardial fibrosis as determined by the presence of HE. However, there was a predilection of myocardial fibrosis for specific locations. In particular, the junction of the RV freewall with the interventricular septum was commonly involved (100% at the inferior septal junction, 56% at the anterior septal junction). Six patients (22%) had direct involvement of the right ventricular free wall. The extent of HE correlated with RVEDV and RVESV (p<0.01). In addition, QRS duration correlated with RVEDV, RVESV, and RVEF (p<0.05, all). Conclusion: Patients with repaired conotruncal congenital heart defects such as TOF and TGA have areas of myocardial fibrosis that are located remote from sites of direct surgical intervention. The concentration of myocardial fibrosis in these unexpected locations remains to be explained. The extent of fibrosis in these patients and QRS duration correlates with adverse right ventricular morphology and function. Future investigations of the relationship between right ventricular fibrosis characteristics and outcomes in this patient population are necessary.
Background: Ventricular dysfunction of the systemic right ventricle (RV) is evident in at least 10% of patients at 10 years and may be caused by a mismatch between O2 demand and supply. Methods: We investigated 20 patients (22.7 SD 4.9 yrs) with TGA after atrial repair (ASO) and 15 patients (30.6 SD 16.4 yrs) with unoperated congenitally corrected transposition (CCTGA); 11 normals (26.2 SD 5.2 yrs) served as controls for the myocardial blood flow (MBF). All patients had spiroergometry, MRI and positron emission tomography (NH3, rest / Adenosine); all ASO patients additionally had cardiac catherization. Results: MBFrest did not differ between patients with ASO, CCTGA and controls, whilst MBFstress (ASO 167 SD 46* vs. CCTGA 198 SD 38* vs. controls 310 SD 74 ml/100g/ min.; p<0.001) and coronary flow reserve (ASO 2.3 SD 0.4* vs. CCTGA 2.6 SD 0.6* vs. controls 4.1 SD 0.7; p<0.001) were significantly reduced; angiography did not show any stenosis of the coronary arteries, suggesting microvascular disease. In both patient groups a negativ correlation between ventricular mass and MBFrest could be calculated. In CCTGA there additionally was a significant correlation between CFR and the increase of the systolic function after dobutamine administration on MRI (r=0.71; p<0.01), BNPlevels (r=0.69; p<0.01) and VO2 max. (r=0.62; p<0.01) . In patients with ASO, CFR is not significantly correlated with ventricular function, BNP and VO2 max, suggesting a multifactorial process (attenuated atrial compliance with reduced preload). Conclusion: The intrinsic geometry of the systemic RV and the process of remodelling (myocyte hypertrophy and disarray, interstitial fibrosis, inadequate capillary growth, thickening of the media of intramural coronary arteries) may contribute to limited nutritional support with ventricular deterioration and electrical instability; the mismatch between O2 demand and supply is an important risk factor for the long-term prognosis of patients with morphologic right ventricle; in patients with TGA after atrial repair it is at least one important cofactor causing ventricular deterioration.
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Bicuspid Aortic Valve Background: Some patients with Fontan palliation for univentricular congenital heart disease will eventually fail and require orthotopic heart transplantation (OHT).This particular mode of cardiovascular failure has been investigated in the past focusing primarily on the Fontan pathway and its obstruction. We sought to describe and define the clinical-pathologic events that occur in the univentricular heart. Methods: We retrospectively analyzed the data from 31 patients (19 males and 12 females) with Fontan physiology who underwent OHT at a mean age of 17 years (range, 7-48) with special emphasis on the pathological changes of the explanted heart. Results: All 31 patients were in NYHA class III or IV, and 14/31 required pacemaker therapy for arrhythmias (10/14 atrial dysrhythmias, 1/14 junctional bradycardia, 2/14 ventricular tachycardia, and 1/14 sick sinus syndrome). The mean Fontan pressure was 24.5 mmHg (range, 7-26) . Echo data available in 24/31 revealed a mean ejection fraction of 23% (range, 10-45) . In 19/24 patients atrioventricular valve regurgitation was moderate to severe in 11/19 and mild in 7/19. Mean heart weight was 371g (range, 120-880) . The mean percentage of hypertrophy based on the patient's height was 156% (range, 60-436). Microscopically, fibrosis was present in all but one explanted heart: 10/31 had interstitial fibrosis, 13/31 had replacement fibrosis, 7/31 had both, and 1/31 had myocardial fibroelastosis. The mean free ventricular wall thickness was 1.75 cm (range, 1.0-3.2). Conclusion: Failing univentricular hearts with Fontan circulation demonstrate similar clinicopathologic changes to the biventricular hearts that fail. These findings argue for routine anticongestive medical therapy post-Fontan to delay and/or prevent adverse remodeling and failure of the univentricular heart. A prospective trial is proposed to address this issue.
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840-5 Should Mechanical Valves Be Used in the Pulmonary Position
John M. Stulak, Heidi M. Connolly, Francisco J. Puga, Joseph A. Dearani, Carole A. Warnes, Hartzell V. Schaff, Mayo Clinic, Rochester, MN Objectives: Bioprostheses are the most commonly used valve substitutes in the pulmonary position, but most require late re-replacement. Mechanical valves may have better durability, but there are conflicting reports regarding late outcome of these prostheses for pulmonary valve replacement (PVR). Methods: We reviewed 10 patients (pts) (27 +/-12 years (yrs)) who underwent mechanical PVR between January 1969 and June 2002. Diagnoses included carcinoid heart disease (n=4), double outlet right ventricle (n=2), pulmonary stenosis/atresia (n=2), transposition of the great arteries (n=1), and truncus arteriosus (n=1). Eight had PVR at our institution and 2 pts underwent PVR elsewhere.
